がん用二重特異性抗体市場は2023年から2028年に3億1,430万米ドル、予測期間中のCAGRは6.78％で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。がんの有病率の増加、モノクローナル抗体に対する二特異性抗体の優位性、強力なパイプラインなどが市場を牽引しています。
この調査では、今後数年間のがん用二重特異性抗体市場成長を牽引する主要因の一つとして、新たな二重特異性抗体作製プラットフォームを挙げています。また、戦略的提携の増加や中国における強力な研究開発が市場の大きな需要につながります。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Bispecific Antibodies For Cancer Market 2018 - 2022
Historic Market Size - Data Table on Global Bispecific Antibodies For Cancer Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Distribution Channel segment analysis 2018 - 2022
Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 CD19 or CD3 - Market size and forecast 2023-2028
Chart on CD19 or CD3 - Market size and forecast 2023-2028 ($ million)
Data Table on CD19 or CD3 - Market size and forecast 2023-2028 ($ million)
Chart on CD19 or CD3 - Year-over-year growth 2023-2028 (%)
Data Table on CD19 or CD3 - Year-over-year growth 2023-2028 (%)
6.4 CD30 or CD16A - Market size and forecast 2023-2028
Chart on CD30 or CD16A - Market size and forecast 2023-2028 ($ million)
Data Table on CD30 or CD16A - Market size and forecast 2023-2028 ($ million)
Chart on CD30 or CD16A - Year-over-year growth 2023-2028 (%)
Data Table on CD30 or CD16A - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
Chart on Distribution Channel - Market share 2023-2028 (%)
Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
7.3 Hospitals - Market size and forecast 2023-2028
Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
7.4 Retail pharmacies - Market size and forecast 2023-2028
Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
7.5 Online - Market size and forecast 2023-2028
Chart on Online - Market size and forecast 2023-2028 ($ million)
Data Table on Online - Market size and forecast 2023-2028 ($ million)
Chart on Online - Year-over-year growth 2023-2028 (%)
Data Table on Online - Year-over-year growth 2023-2028 (%)
7.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share by geography 2023-2028 (%)
Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Ireland - Market size and forecast 2023-2028
Chart on Ireland - Market size and forecast 2023-2028 ($ million)
Data Table on Ireland - Market size and forecast 2023-2028 ($ million)
Chart on Ireland - Year-over-year growth 2023-2028 (%)
Data Table on Ireland - Year-over-year growth 2023-2028 (%)
9.9 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
9.10 Hungary - Market size and forecast 2023-2028
Chart on Hungary - Market size and forecast 2023-2028 ($ million)
Data Table on Hungary - Market size and forecast 2023-2028 ($ million)
Chart on Hungary - Year-over-year growth 2023-2028 (%)
Data Table on Hungary - Year-over-year growth 2023-2028 (%)
9.11 India - Market size and forecast 2023-2028
Chart on India - Market size and forecast 2023-2028 ($ million)
Data Table on India - Market size and forecast 2023-2028 ($ million)
Chart on India - Year-over-year growth 2023-2028 (%)
Data Table on India - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Market opportunity by geography ($ million)
Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 ABL Bio Inc.
ABL Bio Inc. - Overview
ABL Bio Inc. - Product / Service
ABL Bio Inc. - Key offerings
12.4 AFFIMED N.V.
AFFIMED N.V. - Overview
AFFIMED N.V. - Product / Service
AFFIMED N.V. - Key news
AFFIMED N.V. - Key offerings
12.5 Akeso Inc.
Akeso Inc. - Overview
Akeso Inc. - Product / Service
Akeso Inc. - Key offerings
12.6 Amgen Inc.
Amgen Inc. - Overview
Amgen Inc. - Product / Service
Amgen Inc. - Key news
Amgen Inc. - Key offerings
12.7 Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc. - Overview
Aptevo Therapeutics Inc. - Product / Service
Aptevo Therapeutics Inc. - Key offerings
12.8 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product / Service
Astellas Pharma Inc. - Key news
Astellas Pharma Inc. - Key offerings
12.9 Chugai Pharmaceutical Co. Ltd.
Chugai Pharmaceutical Co. Ltd. - Overview
Chugai Pharmaceutical Co. Ltd. - Product / Service
Chugai Pharmaceutical Co. Ltd. - Key news
Chugai Pharmaceutical Co. Ltd. - Key offerings
12.10 Eli Lilly and Co.
Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key news
Eli Lilly and Co. - Key offerings
12.11 EPIMAB BIOTHERAPEUTICS INC.
EPIMAB BIOTHERAPEUTICS INC. - Overview
EPIMAB BIOTHERAPEUTICS INC. - Product / Service
EPIMAB BIOTHERAPEUTICS INC. - Key offerings
12.12 F STAR THERAPEUTICS INC.
F STAR THERAPEUTICS INC. - Overview
F STAR THERAPEUTICS INC. - Product / Service
F STAR THERAPEUTICS INC. - Key offerings
12.13 F. Hoffmann La Roche Ltd.
F. Hoffmann La Roche Ltd. - Overview
F. Hoffmann La Roche Ltd. - Business segments
F. Hoffmann La Roche Ltd. - Key news
F. Hoffmann La Roche Ltd. - Key offerings
F. Hoffmann La Roche Ltd. - Segment focus
12.14 Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd. - Overview
Glenmark Pharmaceuticals Ltd. - Product / Service
Glenmark Pharmaceuticals Ltd. - Key news
Glenmark Pharmaceuticals Ltd. - Key offerings
12.15 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
12.16 Mereo BioPharma Group Plc
Mereo BioPharma Group Plc - Overview
Mereo BioPharma Group Plc - Product / Service
Mereo BioPharma Group Plc - Key offerings
12.17 Merus N.V.
Merus N.V. - Overview
Merus N.V. - Product / Service
Merus N.V. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Company Market Positioning
Exhibits10: Parent Market
Exhibits11: Data Table on - Parent Market
Exhibits12: Market characteristics analysis
Exhibits13: Value Chain Analysis
Exhibits14: Offerings of companies included in the market definition
Exhibits15: Market segments
Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits20: Historic Market Size - Data Table on Global Bispecific Antibodies For Cancer Market 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits25: Five forces analysis - Comparison between 2023 and 2028
Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits31: Chart on Market condition - Five forces 2023 and 2028
Exhibits32: Chart on Type - Market share 2023-2028 (%)
Exhibits33: Data Table on Type - Market share 2023-2028 (%)
Exhibits34: Chart on Comparison by Type
Exhibits35: Data Table on Comparison by Type
Exhibits36: Chart on CD19 or CD3 - Market size and forecast 2023-2028 ($ million)
Exhibits37: Data Table on CD19 or CD3 - Market size and forecast 2023-2028 ($ million)
Exhibits38: Chart on CD19 or CD3 - Year-over-year growth 2023-2028 (%)
Exhibits39: Data Table on CD19 or CD3 - Year-over-year growth 2023-2028 (%)
Exhibits40: Chart on CD30 or CD16A - Market size and forecast 2023-2028 ($ million)
Exhibits41: Data Table on CD30 or CD16A - Market size and forecast 2023-2028 ($ million)
Exhibits42: Chart on CD30 or CD16A - Year-over-year growth 2023-2028 (%)
Exhibits43: Data Table on CD30 or CD16A - Year-over-year growth 2023-2028 (%)
Exhibits44: Market opportunity by Type ($ million)
Exhibits45: Data Table on Market opportunity by Type ($ million)
Exhibits46: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits47: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits48: Chart on Comparison by Distribution Channel
Exhibits49: Data Table on Comparison by Distribution Channel
Exhibits50: Chart on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits51: Data Table on Hospitals - Market size and forecast 2023-2028 ($ million)
Exhibits52: Chart on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits53: Data Table on Hospitals - Year-over-year growth 2023-2028 (%)
Exhibits54: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits55: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
Exhibits56: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits57: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits58: Chart on Online - Market size and forecast 2023-2028 ($ million)
Exhibits59: Data Table on Online - Market size and forecast 2023-2028 ($ million)
Exhibits60: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits61: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits62: Market opportunity by Distribution Channel ($ million)
Exhibits63: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits65: Chart on Market share by geography 2023-2028 (%)
Exhibits66: Data Table on Market share by geography 2023-2028 (%)
Exhibits67: Chart on Geographic comparison
Exhibits68: Data Table on Geographic comparison
Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits89: Chart on Ireland - Market size and forecast 2023-2028 ($ million)
Exhibits90: Data Table on Ireland - Market size and forecast 2023-2028 ($ million)
Exhibits91: Chart on Ireland - Year-over-year growth 2023-2028 (%)
Exhibits92: Data Table on Ireland - Year-over-year growth 2023-2028 (%)
Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits97: Chart on Hungary - Market size and forecast 2023-2028 ($ million)
Exhibits98: Data Table on Hungary - Market size and forecast 2023-2028 ($ million)
Exhibits99: Chart on Hungary - Year-over-year growth 2023-2028 (%)
Exhibits100: Data Table on Hungary - Year-over-year growth 2023-2028 (%)
Exhibits101: Chart on India - Market size and forecast 2023-2028 ($ million)
Exhibits102: Data Table on India - Market size and forecast 2023-2028 ($ million)
Exhibits103: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits104: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits105: Market opportunity by geography ($ million)
Exhibits106: Data Tables on Market opportunity by geography ($ million)
Exhibits107: Impact of drivers and challenges in 2023 and 2028
Exhibits108: Overview on criticality of inputs and factors of differentiation
Exhibits109: Overview on factors of disruption
Exhibits110: Impact of key risks on business
Exhibits111: Companies covered
Exhibits112: Matrix on companies position and classification
Exhibits113: ABL Bio Inc. - Overview
Exhibits114: ABL Bio Inc. - Product / Service
Exhibits115: ABL Bio Inc. - Key offerings
Exhibits116: AFFIMED N.V. - Overview
Exhibits117: AFFIMED N.V. - Product / Service
Exhibits118: AFFIMED N.V. - Key news
Exhibits119: AFFIMED N.V. - Key offerings
Exhibits120: Akeso Inc. - Overview
Exhibits121: Akeso Inc. - Product / Service
Exhibits122: Akeso Inc. - Key offerings
Exhibits123: Amgen Inc. - Overview
Exhibits124: Amgen Inc. - Product / Service
Exhibits125: Amgen Inc. - Key news
Exhibits126: Amgen Inc. - Key offerings
Exhibits127: Aptevo Therapeutics Inc. - Overview
Exhibits128: Aptevo Therapeutics Inc. - Product / Service
Exhibits129: Aptevo Therapeutics Inc. - Key offerings
Exhibits130: Astellas Pharma Inc. - Overview
Exhibits131: Astellas Pharma Inc. - Product / Service
Exhibits132: Astellas Pharma Inc. - Key news
Exhibits133: Astellas Pharma Inc. - Key offerings
Exhibits134: Chugai Pharmaceutical Co. Ltd. - Overview
Exhibits135: Chugai Pharmaceutical Co. Ltd. - Product / Service
Exhibits136: Chugai Pharmaceutical Co. Ltd. - Key news
Exhibits137: Chugai Pharmaceutical Co. Ltd. - Key offerings
Exhibits138: Eli Lilly and Co. - Overview
Exhibits139: Eli Lilly and Co. - Product / Service
Exhibits140: Eli Lilly and Co. - Key news
Exhibits141: Eli Lilly and Co. - Key offerings
Exhibits142: EPIMAB BIOTHERAPEUTICS INC. - Overview
Exhibits143: EPIMAB BIOTHERAPEUTICS INC. - Product / Service
Exhibits144: EPIMAB BIOTHERAPEUTICS INC. - Key offerings
Exhibits145: F STAR THERAPEUTICS INC. - Overview
Exhibits146: F STAR THERAPEUTICS INC. - Product / Service
Exhibits147: F STAR THERAPEUTICS INC. - Key offerings
Exhibits148: F. Hoffmann La Roche Ltd. - Overview
Exhibits149: F. Hoffmann La Roche Ltd. - Business segments
Exhibits150: F. Hoffmann La Roche Ltd. - Key news
Exhibits151: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits152: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits153: Glenmark Pharmaceuticals Ltd. - Overview
Exhibits154: Glenmark Pharmaceuticals Ltd. - Product / Service
Exhibits155: Glenmark Pharmaceuticals Ltd. - Key news
Exhibits156: Glenmark Pharmaceuticals Ltd. - Key offerings
Exhibits157: Johnson and Johnson Services Inc. - Overview
Exhibits158: Johnson and Johnson Services Inc. - Business segments
Exhibits159: Johnson and Johnson Services Inc. - Key news
Exhibits160: Johnson and Johnson Services Inc. - Key offerings
Exhibits161: Johnson and Johnson Services Inc. - Segment focus
Exhibits162: Mereo BioPharma Group Plc - Overview
Exhibits163: Mereo BioPharma Group Plc - Product / Service
Exhibits164: Mereo BioPharma Group Plc - Key offerings
Exhibits165: Merus N.V. - Overview
Exhibits166: Merus N.V. - Product / Service
Exhibits167: Merus N.V. - Key offerings
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Information sources
Exhibits173: Data validation
Exhibits174: Validation techniques employed for market sizing
Exhibits175: Data synthesis
Exhibits176: 360 degree market analysis
Exhibits177: List of abbreviations
